Physicians Realty Trust Coverage Initiated at JMP Securities (DOC)
Investment analysts at JMP Securities assumed coverage on shares of Physicians Realty Trust (NYSE:DOC) in a note issued to investors on Monday, Analyst RN reports. The firm set an “outperform” rating and a $15.00 price target on the stock. JMP Securities’ price objective points to a potential upside of 16.82% from the stock’s previous close.
Separately, analysts at Compass Point raised their price target on shares of Physicians Realty Trust from $13.00 to $15.00 in a research note to investors on Monday, October 21st. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a buy rating, Physicians Realty Trust currently has an average rating of “Buy” and a consensus price target of $14.67.
Physicians Realty Trust (NYSE:DOC) opened at 12.84 on Monday. Physicians Realty Trust has a 52-week low of $11.00 and a 52-week high of $13.00. The stock has a 50-day moving average of $12.09 and a 200-day moving average of $12.06. The company’s market cap is $260.7 million.
Physicians Realty Trust (NYSE:DOC) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.03. On average, analysts predict that Physicians Realty Trust will post $0.27 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, February 7th. Stockholders of record on Friday, January 24th will be paid a dividend of 0.225 per share. This represents a $0.90 annualized dividend and a dividend yield of 7.01%. The ex-dividend date is Wednesday, January 22nd. This is a boost from Physicians Realty Trust’s previous quarterly dividend of $0.18.
Physicians Realty Trust is a real estate investment trust (NYSE:DOC).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.